Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.12.2021 | Case report

Antineoplastics

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Voruz S, et al. Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine. Experimental Hematology and Oncology 10: No. 1, 2021. Available from: URL: http://www.ehoonline.org/ Voruz S, et al. Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine. Experimental Hematology and Oncology 10: No. 1, 2021. Available from: URL: http://​www.​ehoonline.​org/​
Metadaten
Titel
Antineoplastics
Lack of efficacy: case report
Publikationsdatum
01.12.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-06370-4

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Sorafenib

Case report

Vandetanib

Case report

mRNA-1273

Case report

Nandrolone abuse